ArticleFrontiers in cardiovascular medicine2025
Construction and validation of a prediction model for early recurrence after catheter ablation in patients with persistent atrial fibrillation based on BNP, Ang Ⅱ, homocysteine, MHR, NLR.
Article in Frontiers in cardiovascular medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objective: To explore the feasibility and clinical value of early recurrence prediction model for persistent atrial fibrillation after catheter ablation based on brain natriuretic peptide (BNP), angiotensin Ⅱ(Ang Ⅱ), homocysteine, monocyte-to-high density lipoprotein cholesterol (MHR) and neutrophil-to-lymphocyte ratio (NLR). Methods: 279 patients with persistent atrial fibrillation who underwent catheter ablation in our hospital from January 2022 to December 2024 were divided into training group ( Results: Multivariate Logistic regression analysis showed that diabetes history, elevated BNP, homocysteine, MHR, NLR and Ang Ⅱ were independent risk factors for early postoperative recurrence ( Conclusion: The nomogram prediction model can well predict the early recurrence risk of patients with persistent atrial fibrillation after catheter ablation, and provide a reference for clinical individualized treatment, but it needs further verification by large sample and multi-center research.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.